Determinants of tuberculosis treatment default in Morocco: Results from a national cohort study

Pan African Medical Journal

Volumn 14, Issue , 2013, Pages

  Tachfouti, Nabil ^a   Slama, Katia ^c   Berraho, Mohamed ^a   Elfakir, Samira ^a   Benjelloun, Mohammed Chakib ^b   El Rhazi, Karima ^a   Nejjari, Chakib ^a  

^a Laboratory of Epidemiology   (Morocco)

^b Department of gynecology obstetric I   (Morocco)

^c Epidemiology Unit   (Morocco)

Author keywords

Morocco; Treatment default; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOROCCO; MOSLEM; PATIENT COMPLIANCE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; TUBERCULOSIS CONTROL; URBAN AREA; ADOLESCENT; MEDICATION COMPLIANCE; MIDDLE AGED; STATISTICS; TREATMENT DEFAULT; TUBERCULOSIS;

MOROCCO; TREATMENT DEFAULT; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOROCCO; SMOKING; TUBERCULOSIS; YOUNG ADULT;

EID: 84876482323     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.14.121.2335     Document Type: Article

References (38)

1. Government of India. Revised National TB Control Programme, Status Report. 2009. Central TB Division, Government of India, DGHS. Government of India.
2. World Health Organization. Global tuberculosis report 201 201 Geneva. World Health Organization.
3. World Health Organization. WHO Tuberculosis Programme: framework for effective tuberculosis control. 1994. Geneva. World Health Organisation.
4. Verver S, Warren RM, Beyers N, Richardson M, Van Der Spuy GD et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005; 171(12):1430-5.
5. Ottmani SE, Zignol M, Bencheikh N, Laâsri L, Chaouki N, Mahjour J. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis. 2006 Dec;10(12):1367-72.
6. Dooley KE, Lahlou O, Ghali I, Knudsen J, Elmessaoudi MD, Cherkaoui I, El Aouad R. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health. 2011 Feb; 11:140.
7. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007; (4):CD003343.
8. Vree M, Huong NT, Duong BD, Sy ON, Van le N, Co NV, Cobelens FGJ, Borgdorff MW. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study. BMC Public Health. 2007; 7:134.
9. Kolappan C, Subramani R, Karunakaran K, Narayanan PR. Mortality of tuberculosis patients in Chennai, India. WHO Bulletin. 2006; 84(7): 555-560.
10. Maartens G, Wilkinson RJ. Tuberculosis. Lancet. 2007;370:2030e43.
11. Thomas C. A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. J Manag Med. 2002; 16:371-400.
12. Estifanos Biru S, Bernt L. Determinants of Treatment Adherence among Smear-Positive Pulmonary Tuberculosis patients in Southern Ethiopia. PLoS Medicine. 2007; 4(2): e37.
13. Pefura Yone EW, Kengne AP, Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study. BMJ. 2011; 1.
14. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 1993. Geneva, Switzerland. WHO.
15. TB Unit of the WHO Regional Office for Eastern-Mediterranean Region. WHO Country profile 2008-2009: Morocco. 2008. Geneva. TB Unit of the WHO Regional Office for Eastern-Mediterranean Region.
16. Sanou A, Dembele M, Theobald S, Macq J. Access and adhering to tuberculosis treatment: Barriers faced by patients and communities in Burkina Faso. Int J Tuberc Lung Dis. 2004; 8(12): 1479-1483.
17. Jaiswal A, Singh V, Ogden JA, Porter JD, Sharma PP, et al. Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Trop Med Int Health. 2003;8(7): 625-633.
18. McNagny SE, Ahluwalia JS, Clark WS, Resnicow KA. Cigarette smoking and severe uncontrolled hypertension in inner-city African Americans. Am J Med. 1997; 103(2):121-7.
19. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of non adherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992, 82(12):1607-12.
20. Migliori GB, Hopewell PC, Blasi F et al. Improving the TB case management: The International Standards for Tuberculosis care. Eur Respir J. 2006; 28:687-90.
21. Ait-Khaled N, Alarco ́n E, Armengol R, et al. Prise en charge de la tuberculose:guide des éléments essentiels pour une bonne pratique. 2010. Paris. Union Internationale Contre la Tuberculose et les Maladies Respiratorires.
22. World Health Organization. 2008. http://www.emro.who.int/stb/pdf/CountryProfile-mor-08.pdf. Accessed in 2008.
23. Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004; 4: 68.
24. Ifebunandu NA, Ukwaja KN. Tuberculosis treatment default in a large tertiary care hospital in urban Nigeria: prevalence, trend, timing and predictors. J Infect Public Health. 2012; 5(5):340-5.
25. World Health Organization. 2005 Report, Global tuberculosis control: Surveillance planning, financing. 2005. Geneva. World Health Organization.
26. Muture BN, Keraka M, Kimuu PK, Kabiru E, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: A case control study. BMC Public Health. 2011, 11:696.
27. Demissie M, Kabede D. Defaulting from tuberculosis treatment at the Addis Ababa TB Centre and factors associated with it. Ethiopian Medical Journal. 1994; 32(2):97-106.
28. Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis. 2005 Jun; 58(3):152-8.
29. Bashour H, Mamaree F. Gender differences and tuberculosis in the Syrian Arab Republic: patients? attitudes, compliance and outcomes. East Mediterr Health J. 2003 Jul; 9(4):757-68.
30. O'Boyle SJ, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis. 2002; 6(4):307-12.
31. Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis. 2007; 11(8):828-837.
32. Hasker E, Khodjikhanov M, Usarova S, Asamidinov U, Yuldashova U, van der Werf MJ, Uzakova G, Veen J. Default from tuberculosis treatment in Tashkent, Uzbekistan; who are these defaulters and why do they default? BMC Infect Dis. 2008; 8:97.
33. Kliiman K, Altraja A. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2010 Apr; 14(4):454-63.
34. Park J, Nachman S. The link between religion and HAART adherence in pediatric HIV patients. AIDS Care. 2010 May; 22(5):556-61.
35. Kisenyi RN, Muliira JK, Ayebare E. Religiosity and Adherence to Antiretroviral Therapy Among Patients Attending a Public Hospital-Based HIV/AIDS Clinic in Uganda. J Relig Health. 2013 Mar; 52(1):307-17.
36. Tachfouti N, Berraho M, Elfakir S, Serhier Z, El Rhazi K, Slama K, Nejjari C. Socioeconomic status and tobacco expenditures among Moroccans: Results of the MARTA survey. American Journal of Health Promotion. 2010; 24(5):334-9.
37. Burton NT, Forson A, Lurie MN, Kudzawu S, Kwarteng E, Kwara A. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana. Trans R Soc Trop Med Hyg. 2011; 105(12):675-82.
38. E. Elbireer S, Guwatudde D, Mudiope P, Nabbuye-Sekandi J, Manabe YC. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Tropical Medicine and International Health. 2011; 16: 981-987.